SGS doubles NJ lab capacity; Pfizer licenses OMT's technology;

> SGS has doubled the size of its labs in Fairfield, NJ, offering 30,000 square feet of laboratory space replete with new equipment for biopharmaceutical development. News

> After a similar deal with WuXi PharmaTech ($WX), Open Monoclonal Technology has licensed its rat models to Pfizer ($PFE) for antibody development. Article

> Quintiles has signed a deal with Comprehensive Clinical Development, giving Comprehensive first refusal to work on Quintiles' sponsored clinical trials. More

> JHP Pharmaceuticals says it has inked an agreement with an undisclosed drugmaker to manufacture a lyophilized biologic for late-stage clinical trials. Story

> AMRI has signed a discovery pact with Knopp Biosciences, agreeing to collaborate on central nervous system drugs. Item

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.